We are live on ! Find out more
PCYC

PHARMACYCLICS INC
PCYC

Delisted

PCYC was delisted on the 22nd of May, 2015.

Back to rankings

1 hedge funds and large institutions have $301K invested in PHARMACYCLICS INC in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 333 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 336 → 1 (-335)

100% less funds holding in top 10

Funds holding in top 10: 41 → 0 (-41)

100% less capital invested

Capital invested by funds: $14.3B → $301K (-$14.3B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 333

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-335
Holders Change %
-99.7%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-41
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
333
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$2.46B
2
BBA
Baker Bros. Advisors
New York
-$2.31B
3
Vanguard Group
Vanguard Group
Pennsylvania
-$1B
4
Primecap Management
Primecap Management
California
-$585M
5
PCM
Pentwater Capital Management
Florida
-$572M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bessemer Group
226
Bessemer Group
New Jersey
– -$1.1M -4,290 Closed
MLICM
227
Metropolitan Life Insurance Company (MetLife)
New York
– -$1.1M -4,290 Closed
Rafferty Asset Management
228
Rafferty Asset Management
New York
– -$1.08M -4,216 Closed
VKH
229
Virtu KCG Holdings
New York
– -$1.06M -4,149 Closed
Stifel Financial
230
Stifel Financial
Missouri
– -$1.05M -4,100 Closed
William Blair & Company
231
William Blair & Company
Illinois
– -$1.04M -4,071 Closed
KBC Group
232
KBC Group
Belgium
– -$1.03M -4,034 Closed
RFC
233
Russell Frank Company
Washington
– -$1.02M -3,994 Closed
DADC
234
D.A. Davidson & Co
Montana
– -$1.01M -3,960 Closed
FHC
235
First Heartland Consultants
Missouri
– -$1.01M -3,940 Closed
CEP
236
Chicago Equity Partners
Illinois
– -$999K -3,905 Closed
WBC
237
Westpac Banking Corp
Australia
– -$1.11M -3,890 Closed
SI
238
Stephens Inc
Arkansas
– -$936K -3,656 Closed
Wellington Management Group
239
Wellington Management Group
Massachusetts
– -$898K -3,509 Closed
HK
240
Horizon Kinetics
New York
– -$846K -3,305 Closed
CPA
241
Cowen Prime Advisors
New York
– -$845K -3,300 Closed
KAM
242
Kassirer Asset Management
Ontario, Canada
– -$845K -3,300 Closed
WS
243
Wedbush Securities
California
– -$840K -3,280 Closed
CAM
244
Centre Asset Management
New York
– -$837K -3,270 Closed
NPC
245
National Planning Corporation
California
– -$826K -3,254 Closed
DL
246
Delta Lloyd
Netherlands
– -$829K -3,240 Closed
ID
247
Integral Derivatives
New York
– -$819K -3,200 Closed
LPL Financial
248
LPL Financial
California
– -$805K -3,154 Closed
Truist Financial
249
Truist Financial
North Carolina
– -$802K -3,134 Closed
BNP Paribas Asset Management
250
BNP Paribas Asset Management
France
– -$786K -3,069 Closed
8 9
10
11 12

PCYC Hedge Fund Activity: Q2 2015 in Review

1 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in PHARMACYCLICS INC (PCYC) for Q2 2015, worth a combined $301K — down 100% from $14.3B a quarter earlier.

Sellers outnumbered buyers: 333 funds closed out of PCYC and 0 opened new positions — a net loss of 333 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $2.46B sold.

  • 1 institutional investor held PHARMACYCLICS INC (PCYC) as of Q2 2015, down from 336 in Q1 2015.
  • Funds reported $301K of PHARMACYCLICS INC stock for Q2 2015, down 100% quarter-over-quarter.
  • 0 funds opened new PHARMACYCLICS INC positions in Q2 2015 and 333 closed out, a net change of -333 holders.
  • The largest PHARMACYCLICS INC seller in Q2 2015 was T. Rowe Price Associates, an estimated $2.46B sold.

Based on aggregated 13F filings for Q2 2015.